Status:
RECRUITING
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
Lead Sponsor:
Montefiore Medical Center
Collaborating Sponsors:
The Cleveland Clinic
University of Toronto
Conditions:
Tricuspid Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedur...
Detailed Description
The primary aims of the registry will be: * To examine the safety, efficacy, and long-term outcomes of TTVR * To assess the incidence of procedural complications and their correlations with adverse c...
Eligibility Criteria
Inclusion
- Patients undergoing Transcatheter Tricuspid Valve Replacement
- Native Tricuspid Valve disease
- Orthotopic Tricuspid Valve Implantation
Exclusion
- Age under 18 years
Key Trial Info
Start Date :
October 5 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06033274
Start Date
October 5 2023
End Date
August 1 2026
Last Update
September 10 2025
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Arizona Heart Hospital (Biltmore Cardiology)
Phoenix, Arizona, United States, 85016
2
Columbia University Irving Medical Center
New York, New York, United States, 10032
3
Montefiore Medical Center
The Bronx, New York, United States, 10461
4
Cleveland Clinic
Cleveland, Ohio, United States, 44195